Q: Are you an 'AgTech' company?

A: No, we are an "ingredient infrastructure company", delivering "high impact nutrition interventions" for a "post-UPF world". The Automated Selective Harvesters ('Harvesta') robotic technology is how we secure a low-cost proprietary feedstock that we monetize to the benefit of the planter (farmer) and ourselves. The data offer ('Intellia') is being developed to further improve farmer productivity and further enhance positive environmental benefits. You could also argue we are a 'biotech' company due to our 'Reacta' process, though the ingredients we produce have 'minimal' processing so they retain their goodness. So, while we create a long-term competitive advantage using a sophisticated bundle of integrated technologies that represents a defensible 'moat', we are essentially a food ingredient company focused on the alternative protein and fibre enrichment ingredients markets, predominantly in the UK + Europe and the US.

Q: How do you define the ingredients markets you serve?

UPP is not a broad food-tech bet, but a focused ingredient infrastructure company with a defensible route into high-value nutrition markets. While UPP operates in a large, expanding ingredient market, our commercial focus is deliberately narrower than headline numbers. Total Addressable Market ('TAM') is defined as the global protein and fibre ingredient markets relevant to UPP’s product set, supported by third-party estimates of USD ~15bn for alternative protein in 2023 and USD ~8bn for digestive fibre ingredients in 2024. Serviceable Addressable Market ('SAM') is the serviceable base of food manufacturers seeking standardised, functional ingredients. Serviceable Obtainable Market ('SOM') is the portion of that market UPP can realistically capture through its competitive advantage resulting from feedstock access, selective harvesting, and ingredient standardisation.

Our TAM is the global spend on ingredient categories that food manufacturers buy to improve protein, fibre, nutrition, cost, or sustainability in existing products. That includes plant-protein and functional-fibre ingredient demand in mainstream prepared foods, hybrid meat products, bakery, sauces, soups, pasta, and adjacent applications. This is not covered in isolation by analysts.

Terms such as “alternative proteins” and “fibre enrichment ingredients” are not standardized labels across market research publishers. For alternative proteins, alternative category labels includes plant-based, fermentation or microbe-based, and insect protein. For fiber/fibre enrichment, other labels include "fiber and specialty carbohydrates" (for a broader ingredient-market view) or "dietary fibers". In the references below you will find links to market research reports from companies that cover the area, and that give an order of magnitude of the market sizes for our focus markets. Inevitably, different publishers segment markets differently, have different forecast periods, and have different views so the reports do not fully align. Values are stated in USD as that is currency the publishers use.

In aggregate, this third-party analysis supports a TAM for UPP for protein ('Prota', Prota+') and fibre/fiber ('Fiba', 'Bynda') of: United Kingdom: USD 650-2,050m, United States: USD 6,400-8,000m and Global: USD 21,000-30,000m. For the UK, the total market size for food production is ~£95bn, and food service ~£108bn, so a figure of <1% of the combined total as a TAM appears directionally viable. Annual US food manufacture is valued at ~$904bn and food service is valued at ~$1,144bn, which gives comfort as to the reasonableness of the US TAM. A TAM for the US of 8x (range 4-10x) greater than that of the UK appears similarly reasonable.

Our SAM is much narrower than the sector backdrop defined as TAM. The defensible SAM is UK-first and near-term EU food manufacturers, selected private-label supply chains, and foodservice-linked producers that can adopt non-novel brassica protein and fibre into existing products with limited technical change. The current serviceable applications are mainstream reformulation use cases, especially hybrid meat, plant-based prepared foods, sauces, soups, bakery, pasta, and related convenience products. This fits our go-to-market: low-friction reformulation, Tier-1 focus, "deployable now", and inclusion rates of roughly 4–30% (depending on application).

Our SAM is therefore "supermarket food manufacturers and foodservice in relation to hybrid meat and plant-based prepared foods, sauces, and bakery" in target markets (UK, Europe, US). We regard mycelium feedstock and future products (Ova, Ola, Isa, Myca etc.) as adjacent future segments, outside the current SAM.

It is stressed that UPP operates within a large global ingredient opportunity spanning plant protein and functional fibre, but our near-term commercial focus is much narrower: UK-first and near-term EU food manufacturers (by export) reformulating existing products with non-novel brassica ingredients followed by US market activation (initially by export, until a production facility is economic).

The company’s SOM over the next few years is best understood as a function of customer approval progress and available output capacity, rather than as a simple percentage of a headline sector market. Accordingly, we present TAM as category context, SAM as a potential set of reformulation applications for target customer groups, and SOM as capacity-backed revenue (on an annual equivalent basis) that can be won through the current pipeline and scale-up roadmap over the next 36 months given planned products, capacity, approvals, and estimated pipeline conversion. We estimate the 36 month SAM and target SOM as follows:

UK: SAM USD 269m; SOM USD 25-40m (8.4-20.7%)

Europe: SAM USD 1,117m; SOM USD 25-40m (2.2-5.1%)

US: SAM USD 1,664m; SOM USD 25-40m (1.5-3.2%)

References

Alternative proteins: Grand View Research, UK Alternative Protein Market Size & Outlook 2023–2030, U.S. Alternative Protein Market Size & Outlook, 2023–2030 and Global Alternative Protein Market Size & Outlook, 2023–2030.

UK: USD 1,151.8 million in 2023; forecast USD 2,003.2 million by 2030.

US: USD 4,464.5 million in 2023; forecast USD 7,423.3 million by 2030.

Global: USD 15,287.7 million in 2023; forecast USD 26,519.9 million by 2030.

Plant-based protein: Mordor Intelligence, United Kingdom Plant Protein Market Size & Growth to 2031, United States Plant Protein Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031), and Plant Protein Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031).

UK: USD 453.21 million in 2026; forecast USD 604.18 million by 2031.

US: USD 4.81 billion in 2026; from a 2025 base of USD 4.61 billion; forecast USD 5.95 billion by 2031.

Global: USD 13.66 billion in 2026; from a 2025 value of USD 13.05 billion; forecast USD 17.16 billion by 2031.

Fibre enrichment ingredients market: Grand View Research, UK Fiber and Specialty Carbohydrates Market Size & Outlook, U.S. report: U.S. Fiber And Specialty Carbohydrates Market Size & Outlook, and Global report: Fiber And Specialty Carbohydrates Market Size Report, 2030.

UK: USD 894.8 million in 2024; forecast USD 1,216.6 million by 2030.

US: USD 3,487.9 million in 2024; forecast USD 4,645.5 million by 2030.

Global: USD 14.83 billion in 2024

Dietary fibers: Grand View Research, UK Dietary Fibers Market Size & Outlook, 2023–2030, U.S. Dietary Fibers Market Size & Outlook, 2023–2030, and Global Dietary Fibers Market Size & Outlook, 2023–2030.

UK: USD 197.9 million in 2023; forecast USD 350.6 million by 2030.

US: USD 1,897.2 million in 2023; forecast USD 3,436.3 million by 2030.

Global: USD 7,947.6 million in 2023; forecast USD 14,925.7 million by 2030.

These market sizes may be validated by triangulation with the following:

Plant-based protein

MarketsandMarkets for plant-based protein: Estimating USD 23.89B in 2025 and USD 34.97B by 2030.

Future Market Insights for plant -based protein: USD 22.0B in 2026 to USD 49.9B by 2036.

Global pea protein market: USD 2.12B in 2023 / USD 2.37B in 2024

Global textured soy protein market: USD 756.3M in 2021, projected as USD 2.19B by 2030

Dietary fibers

MarketsandMarkets: Total market USD 12.3B by 2027.

Soluble fiber: USD 5.04B in 2025 growing to USD 8.14B by 2030. Includes inulin, FOS, beta-glucan, polydextrose, or resistant maltodextrin in beverages, dairy, snacks, or supplements.

Insoluble dietary fibers: USD 3.03B in 2026 growing to USD 4.28B by 2031. Relevant to bakery, cereals, bulking, and texture-led fortification than for gut-health/prebiotic positioning.

Prebiotics / prebiotic ingredients: USD 11.10B in 2025 to USD 32.91B by 2033

Inulin: USD 1.84B in 2024, rising to USD 2.71B by 2030.

Pea fiber: USD 1.23B in 2025 growing to USD 1.59B by 2030.

About UPP

Q: What is your unique selling point?

A: UPP’s category moat sits at the intersection of agriculture, processing, and ingredients, not in any single step. By controlling how under-utilised crops are selectively harvested in-field, how that variable biological input is stabilised and fractionated, and how finished ingredients are standardised for food-grade use, UPP creates a system competitors cannot replicate by copying a recipe or buying commodity feedstock. The patented selective harvesting technology enables access to consistent, low-cost raw material that others cannot economically or reliably source at scale; the patent-filed production process converts that material into functional protein and fibre ingredients with repeatable performance; and the operational know-how linking field data to manufacturing output allows UPP to deliver ingredient-grade consistency from inherently inconsistent crops. Together, this end-to-end control creates a "category moat": competitors would need to solve agriculture, hardware, processing, and quality simultaneously to compete on cost, consistency, and scalability, raising both capital and execution barriers well beyond those of a typical ingredient or food-tech company.

Specifically, our Automated Selective Harvester ('Harvesta') transforms broccoli production economics and allows realisation of the side stream, which would be uneconomic/impractical without it. Harvesta 'unlocks' the problem of utilisation and monetization of side stream, which allows a transformational business model. We have a granted patent for our Automated Selective Harvester (GB2608367A, US20240206393A1, EP4362656A1). Other patent filings are in progress.

Further, we expect the insight produced from the data we gather to create further value for farmers by helping them improve productivity and reduce costs. We see this service (branded 'Intellia') as reinforcing the value we offer and the advantage of working with us.

In addition a patent has been filed for protein production (GB2408157.2, PCT/GB2025/051208) and our 'Reacta' process and key ingredient ("Bia") are trade secrets. Other patents are in development.

Q: Are you associated with Uppal farm?

A: No, we are completely different organisations.